Manulife (Manufacturers Life Insurance)’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.5K | Buy |
+34,131
| New | +$48.5K | ﹤0.01% | 2891 |
|
|
2024
Q2 | – | Sell |
-14,788
| Closed | -$18.3K | – | 2961 |
|
|
2024
Q1 | $18.3K | Sell |
14,788
-1,172
| -7% | -$1.45K | ﹤0.01% | 2930 |
|
|
2023
Q4 | $16.8K | Sell |
15,960
-12,014
| -43% | -$12.6K | ﹤0.01% | 2947 |
|
|
2023
Q3 | $192K | Buy |
27,974
+507
| +2% | +$3.47K | ﹤0.01% | 2627 |
|
|
2023
Q2 | $285K | Buy |
27,467
+2,541
| +10% | +$26.4K | ﹤0.01% | 2401 |
|
|
2023
Q1 | $202K | Hold |
24,926
| – | – | ﹤0.01% | 2566 |
|
|
2022
Q4 | $393K | Buy |
24,926
+1,539
| +7% | +$24.2K | ﹤0.01% | 2137 |
|
|
2022
Q3 | $368K | Sell |
23,387
-448
| -2% | -$7.05K | ﹤0.01% | 2171 |
|
|
2022
Q2 | $333K | Buy |
23,835
+2,640
| +12% | +$36.9K | ﹤0.01% | 2328 |
|
|
2022
Q1 | $365K | Sell |
21,195
-5,300
| -20% | -$91.4K | ﹤0.01% | 2387 |
|
|
2021
Q4 | $385 | Sell |
26,495
-84
| -0.3% | -$1 | ﹤0.01% | 2443 |
|
|
2021
Q3 | $478K | Buy |
26,579
+1,864
| +8% | +$33.5K | ﹤0.01% | 2321 |
|
|
2021
Q2 | $434K | Buy |
+24,715
| New | +$434K | ﹤0.01% | 2540 |
|
|
2019
Q2 | – | Sell |
-25,617
| Closed | -$153K | – | 2902 |
|
|
2019
Q1 | $153K | Buy |
25,617
+12,288
| +92% | +$73.4K | ﹤0.01% | 2501 |
|
|
2018
Q4 | $99K | Buy |
13,329
+2,695
| +25% | +$20K | ﹤0.01% | 2440 |
|
|
2018
Q3 | $154K | Sell |
10,634
-10,367
| -49% | -$150K | ﹤0.01% | 2829 |
|
|
2018
Q2 | $420K | Buy |
21,001
+2,866
| +16% | +$57.3K | ﹤0.01% | 2528 |
|
|
2018
Q1 | $317K | Sell |
18,135
-198
| -1% | -$3.46K | ﹤0.01% | 2674 |
|
|
2017
Q4 | $452K | Buy |
18,333
+725
| +4% | +$17.9K | ﹤0.01% | 2386 |
|
|
2017
Q3 | $455K | Buy |
17,608
+1,777
| +11% | +$45.9K | ﹤0.01% | 2336 |
|
|
2017
Q2 | $429K | Buy |
15,831
+6,502
| +70% | +$176K | ﹤0.01% | 2410 |
|
|
2017
Q1 | $278K | Buy |
9,329
+1,567
| +20% | +$46.7K | ﹤0.01% | 2603 |
|
|
2016
Q4 | $211K | Buy |
7,762
+242
| +3% | +$6.58K | ﹤0.01% | 2739 |
|
|
2016
Q3 | $192K | Hold |
7,520
| – | – | ﹤0.01% | 2803 |
|
|
2016
Q2 | $139K | Buy |
7,520
+3,410
| +83% | +$63K | ﹤0.01% | 3010 |
|
|
2016
Q1 | $64K | Buy |
+4,110
| New | +$64K | ﹤0.01% | 3215 |
|